Arbutus Biopharma Long Term Investments Over Time
| ABUS Stock | USD 3.76 0.08 2.17% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Arbutus Biopharma Performance and Arbutus Biopharma Correlation. Arbutus |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arbutus Biopharma. If investors know Arbutus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arbutus Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.43) | Revenue Per Share 0.037 | Quarterly Revenue Growth (0.71) | Return On Assets (0.33) | Return On Equity (0.68) |
The market value of Arbutus Biopharma Corp is measured differently than its book value, which is the value of Arbutus that is recorded on the company's balance sheet. Investors also form their own opinion of Arbutus Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Arbutus Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arbutus Biopharma's market value can be influenced by many factors that don't directly affect Arbutus Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arbutus Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Arbutus Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arbutus Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Long Term Investments Analysis
Compare Arbutus Biopharma Corp and related stocks such as VBI Vaccines, ADMA Biologics, and Adaptimmune Therapeutics Long Term Investments Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AFMD | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 3.8 M | 3.2 M | 20 M | 12.3 M | 0.0 | 0.0 | 0.0 |
| CRVS | 37.2 M | 37.2 M | 37.2 M | 37.2 M | 37.2 M | 37.2 M | 37.2 M | 37.2 M | 37.2 M | 37.2 M | 37.2 M | 34.3 M | 21.9 M | 16.1 M | 21.9 M |
Arbutus Biopharma Corp and related stocks such as VBI Vaccines, ADMA Biologics, and Adaptimmune Therapeutics Long Term Investments description
Long Term Investments is an item on the asset side of Arbutus Biopharma balance sheet that represents investments Arbutus Biopharma Corp intends to hold for over a year. Arbutus Biopharma Corp long term investments may include different instruments such as stocks, bonds, real estate and cash.My Equities
My Current Equities and Potential Positions
| Arbutus Biopharma Corp | ABUS |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | British Columbia; Canada |
| Exchange | NASDAQ Exchange |
USD 3.76
Additional Tools for Arbutus Stock Analysis
When running Arbutus Biopharma's price analysis, check to measure Arbutus Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arbutus Biopharma is operating at the current time. Most of Arbutus Biopharma's value examination focuses on studying past and present price action to predict the probability of Arbutus Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arbutus Biopharma's price. Additionally, you may evaluate how the addition of Arbutus Biopharma to your portfolios can decrease your overall portfolio volatility.